Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | TP53 | P04637 | 3/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 7/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3990182 | 0.98 | ALDH1A1 (0.53) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Sulfuric Acid SCHEMBL8717714 | 0.91 | ALDH1A1 (0.47) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL8976328 | 0.86 | ALDH1A1 (0.43) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Dimethylamine SCHEMBL6114524 | 0.78 | ALDH1A1 (0.53) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Hydrochloric Acid SCHEMBL3317335 | 0.75 | TSHR (0.61) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Hydrochloric Acid SCHEMBL3308705 | 0.75 | TSHR (0.61) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Hydrochloric Acid SCHEMBL3310744 | 0.75 | TSHR (0.61) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| Hydrochloric Acid SCHEMBL28271407 | 0.75 | ALDH1A1 (0.55) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL5696399 | 0.74 | ALDH1A1 (0.50) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL22799958 | 0.74 | ALDH1A1 (0.60) | ALDH1A1TP53HIF1ACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1465676-B1 | FILM-FORMING COMPOSITIONS AND THEIR USES | 3M INNOVATIVE PROPERTIES CO (US) | 2007-08-15 | — | — | EP | claimed |
| US-5783533-A | COPOLYMER CONTAINING ACRYLIC ACID TYPE GROUPS, ACRYLIC, VINYL, OR ALLYL MONOMERS WITH PENDANT AMMONIUM OR SULFONIUM GROUPS, POSSIBLY WITH POLYOXYALKYLENE ETHER SECTION, RHEOLOGY MODIFIERS | COATEX S.A. (FR) | 1998-07-21 | — | — | US | claimed |
| EP-0580529-B1 | Process for making paper or cardboard having improved retention | S N F (FR) | 1996-04-17 | — | — | EP | claimed |
| CN-114514251-B | Polymer dispersions and fabric conditioning compositions comprising the same | 罗地亚经营管理公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-117120588-A | Fabric conditioner | 联合利华知识产权控股有限公司 | 2023-11-24 | — | — | CN | disclosed |
| US-20210046143-A1 | METHOD FOR TREATMENT OF THE HUMAN BODY BY THERAPY BY ADMINISTERING A COMPOSITION COMPRISING A PLANT EXTRACT OF THE SPECIE HEDYCHIUM CORONARIUM | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) | 2021-02-18 | — | — | US | disclosed |
| CN-106459835-B | Composition comprising quaternary ammonium compound, cationic polysaccharide and nonionic polysaccharide | 罗地亚经营管理公司 | 2021-01-26 | — | — | CN | disclosed |
| CN-106414690-B | Methods of using compositions comprising quaternary ammonium compounds, cationic polysaccharides, and nonionic polysaccharides | 罗地亚经营管理公司 | 2021-01-26 | — | — | CN | disclosed |
| CN-107115326-B | Skin pharmaceutical composition of 1-methyl-N- (2, 6-xylyl) -2-piperidine formamide and using method thereof | 雷尔玛达治疗股份有限公司 | 2021-01-22 | — | — | CN | disclosed |
| EP-3064065-B1 | ANTISEPTIC COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-08-12 | — | — | EP | disclosed |
| EP-3562559-A1 | COMPOSITION COMPRISING A PLANT EXTRACT OF THE SPECIE HEDYCHIUM CORONARIUM, FOR USE IN A METHOD FOR TREATMENT OF THE HUMAN BODY BY THERAPY | Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) | 2019-11-06 | — | — | EP | disclosed |
| US-6903243-B1 | Multi-layer absorbent wound dressing | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-06-07 | — | — | US | disclosed |
| US-20050118119-A1 | Use of a compound inactivating the kinase a protein in a composition containg a cosmetically acceptable medium in order to lighten the skin | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (SEPPIC) (FR) | 2005-06-02 | — | — | US | disclosed |
| EP-1465676-A1 | FILM-FORMING COMPOSITIONS AND METHODS | 3M Innovative Properties Company (US) | 2004-10-13 | — | — | EP | disclosed |
| US-20040071642-A1 | Novel topical compositions with an oily outer phase and process for their preparation | SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES-SEPPIC | 2004-04-15 | — | — | US | disclosed |
| WO-2003061721-A1 | FILM-FORMING COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-07-31 | — | — | WO | disclosed |
| US-20030133957-A1 | Topical compositions with outer phase and preparation method | SOCIETE D"EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES-SEPPIC (FR) | 2003-07-17 | — | — | US | disclosed |
| EP-1315527-A2 | MULTI-LAYER ABSORBENT WOUND DRESSING | 3M Innovative Properties Company (US) | 2003-06-04 | — | — | EP | disclosed |
| WO-2002020067-A2 | MULTI-LAYER ABSORBENT WOUND DRESSING | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-03-14 | — | — | WO | disclosed |
| US-5783533-A | COPOLYMER CONTAINING ACRYLIC ACID TYPE GROUPS, ACRYLIC, VINYL, OR ALLYL MONOMERS WITH PENDANT AMMONIUM OR SULFONIUM GROUPS, POSSIBLY WITH POLYOXYALKYLENE ETHER SECTION, RHEOLOGY MODIFIERS | COATEX S.A. (FR) | 1998-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040071642-A1 | Novel topical compositions with an oily outer phase and process for their preparation | CUTA, TYR, ERCC5 | ALDH1A1 273/4885TP53 23/4885HIF1A 1284/4885 |
| US-20030133957-A1 | Topical compositions with outer phase and preparation method | CUTA, LIPA, CETP | ALDH1A1 2254/4885TP53 1311/4885HIF1A 1657/4885 |
| US-20050118119-A1 | Use of a compound inactivating the kinase a protein in a composition containg a cosmetically acceptable medium in order to lighten the skin | PRKACG, PRKACA, PRKACB | ALDH1A1 2852/4885TP53 1547/4885HIF1A 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.